ClinicalTrials.gg
DrugBiological

Pidilizumab clinical trials

Also written CT-011 and MDV9300.

studies test it
14
open now
1
in phase 3
0
first study started
2007

How each study uses pidilizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pidilizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pidilizumab
4
Anti-PD1 Antibody
2

Development codes

CT-011
10
MDV9300
2

Studies by the year they started

14 studies that test it; most in 2009 (3)

Studies that test pidilizumab, by start year
YearStudies
20071
20093
20101
20112
20122
20142
20151
20161
20231

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 7

Medivation, Inc. (3) · CureTech Ltd (3) · Augusta University (2) · M.D. Anderson Cancer Center (1) · CARsgen Therapeutics Co., Ltd. (1) · Ohio State University Comprehensive Cancer Center (1) · Northwestern University (1) · Hadassah Medical Organization (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test pidilizumab.

Studies

Open first, then newest update. How each study uses pidilizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Given beside what is tested · 2 — pidilizumab is usual care or a partner of the new treatment

Codes

What other systems call pidilizumab · ClinicalTrials.gg INT006415

  • MeSH (NLM) C585832pidilizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) B932PAQ1BQPIDILIZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q7191298pidilizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C71014PidilizumabOne source FDA
  • DrugBank DB15383One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.